CHANDRA BARTHOLOMEUSZ to MAP Kinase Kinase 2
This is a "connection" page, showing publications CHANDRA BARTHOLOMEUSZ has written about MAP Kinase Kinase 2.
Connection Strength
0.099
-
MEK1/2 inhibitor selumetinib (AZD6244) inhibits growth of ovarian clear cell carcinoma in a PEA-15-dependent manner in a mouse xenograft model. Mol Cancer Ther. 2012 Feb; 11(2):360-9.
Score: 0.099